Action Plan on Clinical Research

The number of clinical trials conducted in Denmark is to grow by 10 per cent by the end of 2017. This is the target of the government and regions' ambitious action plan on strengthening the conditions for cooperation in clinical research, from May 2014

Clinical research is a necessity for the continuous development of the healthcare system as research in drug treatment and medical devices contribute to improved and more efficient treatment for patients. In May 2014, the Danish government and Danish Regions launched a joint action plan targeted at enhancing public-private sector cooperation on clinical research.

Main target of the action plan is to increase the number of clinical trials in Denmark by 10 per cent by the end of 2017 (including trials initiated by both researchers and pharmaceutical companies). In order to reach this target the action plan presents ten initiatives. Among other things, these initiatives address:

  • Improved patient recruitment using national networks of researchers. A minimum of five new networks will be established by the end of 2017, the first having already been established within the field of respiratory medicine - indsæt link
  • Increased number of early clinical trials - for which the NEXT (National Experimental Therapy) partnership has been established
  • Improved integration of clinical research in clinical practice at hospitals (using e.g. divided positions, combined education)
  • Integrated clinical research among GP’s
  • Improved international promotion and marketing of Denmark’s excellent framework conditions for clinical research

The initiatives of the action plan are being implemented in close collaboration between:

Danish Regions
The Ministry of Health
The Ministry of Higher Education and Science
The Ministry of Foreign Affairs
Danish Association of the Pharmaceutical Industry (LIF).

Read more:

Summary of the Action Plan on clinical research (pdf)